Title of article :
Scranton Type V Osteochondral Defects of Talus: Does one-stage Arthroscopic Debridement, Microfracture and Plasma Rich in Growth Factor cause the Healing of Cyst and Cessation of Progression to Osteoarthritis?
Author/Authors :
N, Singh Department of Orthopaedics and Traumatology - Grande International Hospital - Kathmandu - Nepal , CR, Pandey Department of Orthopaedics and Traumatology - Grande International Hospital - Kathmandu - Nepal , B, Tamang Department of Orthopaedics and Traumatology - Grande International Hospital - Kathmandu - Nepal , R, Singh Department of Physiotherapy and Rehabilitation - Grande International Hospital - Kathmandu - Nepal
Abstract :
Introduction: The study was conducted to evaluate the efficacy of arthroscopic debridement, microfracture and plasma rich in growth factor (PRGF) injection in the
management of type V (Scranton) osteochondral lesions of
talus and its role in healing the subchondral cyst and
cessation of progression of ankle osteoarthritis.
Materials and Methods: This is a prospective case series
conducted on patients who were diagnosed with type V
osteochondral lesions of talus. All the cases were treated
with arthroscopic debridement, microfracture, and PRGF
injections. The patients were evaluated for the healing of
subchondral cysts and progression of osteoarthritis with
radiography (plain radiographs and computerised
tomography Scan). Also, the patients’ outcome was
evaluated with Quadruple Visual Analogue Scale, Ankle
Range of Motion, Foot and Ankle Disability Index, Foot and
Ankle Outcome Instrument and a Satisfaction Questionnaire.
Results: Five male patients underwent arthroscopic
debridement, microfracture and PRGF injection for type V
osteochondral lesion of talus. The mean age of patients was
27.4 years (19-47 years). All the patients gave history of
minor twisting injury. Subchondral cyst healing was
achieved in all patients by six months post-surgery.
However, four out of five patients had developed early
osteoarthritic changes of the ankle by their last follow-up
[mean follow-up 29 months (ranged 15-36 months)]. Despite
arthritic changes, all the patients reported ‘Good’ to
‘Excellent’results on satisfaction questionnaire and Foot and
Ankle Disability Index and could perform their day to day activities including sports.
Conclusion: Arthroscopic debridement, microfracture, and
PRGF causes healing of the subchondral cyst but does not cause cessation of progression to osteoarthritis of ankle in type V osteochondral defects of talus. However, despite progress to osteoarthritis, patient satisfaction post-procedure is good to excellent at short-term follow-up.
Keywords :
scranton type V OCD , microfracture , talus , plasma rich growth factor , osteoarthritis
Journal title :
Malaysian Orthopaedic Journal